In this week’s article we provide a roundup of some of the most recent health and nutrition related articles to be in the news, five items comprising:
It’s that time of year when we say goodbye to the summer and the new school term gets underway. It is also the time of year when due to season changes and numbers of children grouped together inside that there is an increase in common infections such as coughs, colds and flu.
It is estimated that around one in seven UK couples experience difficulty in conceiving, with a poor diet being one of the major contributory factors. Unfortunately, despite its importance for conception and fertility, a lack of nutrition can often be over looked with the most common cause of infertility frequently being labelled as ‘unexplained’.
This week’s article gives an overview of the latest permitted claims authorised by the European Commission and two claims that are currently pending authorisation, including; Calcium and Vitamin D contribute to a reduction in the risk of Bone Mineral Density (BMD) and thus a reduction in the risk of bone fracture; vitamin D contributes to a reduction in the risk of falling (further information for this claim on a recent Cytoplan blog – please follow the link); Zinc contributes to normal growth and finally, Selenium contributes to the protection of DNA, proteins and lipids from oxidative damage.
Our article today is a conversation between Amanda Williams, Managing Director of Cytoplan and Dr Rangan Chatterjee who, post qualification, worked as a hospital doctor for 6 years and has spent the last 7 years working in General Practice around Manchester. His passion is to get to the root cause of problems rather than to just treat symptoms. He specialises in gut health and the immune system, and these areas plus nutrition typically form the core of his new patient consultation and treatment. Continue reading
It’s the recent media story that carries some major health implications for us all and carries a lot of ‘punch’ in terms of the headlines. “DNA-screening test 23andMe launches in UK after US ban: The Google-backed genotyping service can screen for common genetic diseases such as cystic fibrosis or sickle cell anaemia.” ran the Guardian. Whilst the Independent led with “£125 genetic test kit backed by Google arrives in Britain – with a health warning: A Google-backed company that offers a personal genetic screening to test for risk factors associated with diseases such as cancer and Parkinson’s will be available in the UK from today despite deep public health concerns in the US.” 23andMe is named after the 23 pairs of chromosomes in a human cell. Continue reading
